Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 391 entries
Sorted by: Best Match Show Resources per page
Drug induced headache.

Rational drug therapy

Allain HJ, Weintraub M.
PMID: 7422871
Ration Drug Ther. 1980 Jul;14(7):1-6.

No abstract available.

Cite
Allain HJ, Weintraub M. Drug induced headache. Ration Drug Ther. 1980;14(7):1-6
Allain, H. J., & Weintraub, M. (1980). Drug induced headache. Rational drug therapy, 14(7), 1-6.
Allain, H J, and Weintraub, M. "Drug induced headache." Rational drug therapy vol. 14,7 (1980): 1-6.
Allain HJ, Weintraub M. Drug induced headache. Ration Drug Ther. 1980 Jul;14(7):1-6. PMID: 7422871.
Copy Download .nbib Format: NLM
Reflections on 24 Years of Renal Care.

Home hemodialysis international. International Symposium on Home Hemodialysis

Weintraub J.
PMID: 28455867
Home Hemodial Int. 1999 Jan;3(1):72-74. doi: 10.1111/hdi.1999.3.1.72.

No abstract available.

Cite
Weintraub J. Reflections on 24 Years of Renal Care. Home Hemodial Int. 1999;3(1):72-74doi: 10.1111/hdi.1999.3.1.72.
Weintraub, J. (1999). Reflections on 24 Years of Renal Care. Home hemodialysis international. International Symposium on Home Hemodialysis, 3(1), 72-74. https://doi.org/10.1111/hdi.1999.3.1.72
Weintraub, Judy. "Reflections on 24 Years of Renal Care." Home hemodialysis international. International Symposium on Home Hemodialysis vol. 3,1 (1999): 72-74. doi: https://doi.org/10.1111/hdi.1999.3.1.72
Weintraub J. Reflections on 24 Years of Renal Care. Home Hemodial Int. 1999 Jan;3(1):72-74. doi: 10.1111/hdi.1999.3.1.72. PMID: 28455867.
Copy Download .nbib Format: NLM
Mitochondrial Trifunctional Protein Deficiency: Severe Cardiomyopathy and Cardiac Transplantation.

JIMD reports

Bursle C, Weintraub R, Ward C, Justo R, Cardinal J, Coman D.
PMID: 29124685
JIMD Rep. 2018;40:91-95. doi: 10.1007/8904_2017_68. Epub 2017 Nov 10.

We describe mitochondrial trifunctional protein deficiency (MTPD) in two male siblings who presented with severe cardiomyopathy in infancy. The first sibling presented in severe cardiac failure at 6 months of age and succumbed soon after. The second sibling came...

Cite
Bursle C, Weintraub R, Ward C, et al. Mitochondrial Trifunctional Protein Deficiency: Severe Cardiomyopathy and Cardiac Transplantation. JIMD Rep. 2017;40:91-95doi: 10.1007/8904_2017_68.
Bursle, C., Weintraub, R., Ward, C., Justo, R., Cardinal, J., & Coman, D. (2018). Mitochondrial Trifunctional Protein Deficiency: Severe Cardiomyopathy and Cardiac Transplantation. JIMD reports, 4091-95. https://doi.org/10.1007/8904_2017_68
Bursle, C, et al. "Mitochondrial Trifunctional Protein Deficiency: Severe Cardiomyopathy and Cardiac Transplantation." JIMD reports vol. 40 (2018): 91-95. doi: https://doi.org/10.1007/8904_2017_68
Bursle C, Weintraub R, Ward C, Justo R, Cardinal J, Coman D. Mitochondrial Trifunctional Protein Deficiency: Severe Cardiomyopathy and Cardiac Transplantation. JIMD Rep. 2018;40:91-95. doi: 10.1007/8904_2017_68. Epub 2017 Nov 10. PMID: 29124685; PMCID: PMC6122028.
Copy Download .nbib Format: NLM
Good work establishes the need for more research.

Current therapeutic research, clinical and experimental

Weintraub M.
PMID: 24936109
Curr Ther Res Clin Exp. 2004 Jan;65(1):112. doi: 10.1016/S0011-393X(04)90010-0.

No abstract available.

Cite
Weintraub M. Good work establishes the need for more research. Curr Ther Res Clin Exp. 2004;65(1):112doi: 10.1016/S0011-393X(04)90010-0.
Weintraub, M. (2004). Good work establishes the need for more research. Current therapeutic research, clinical and experimental, 65(1), 112. https://doi.org/10.1016/S0011-393X(04)90010-0
Weintraub, Michael. "Good work establishes the need for more research." Current therapeutic research, clinical and experimental vol. 65,1 (2004): 112. doi: https://doi.org/10.1016/S0011-393X(04)90010-0
Weintraub M. Good work establishes the need for more research. Curr Ther Res Clin Exp. 2004 Jan;65(1):112. doi: 10.1016/S0011-393X(04)90010-0. PMID: 24936109; PMCID: PMC4052962.
Copy Download .nbib Format: NLM
Long-Term Treatment with Romidepsin in Patients with Peripheral T-Cell Lymphoma.

Case reports in hematology

Irlé C, Weintraub J.
PMID: 27648317
Case Rep Hematol. 2016;2016:8175957. doi: 10.1155/2016/8175957. Epub 2016 Aug 25.

Peripheral T-cell lymphomas (PTCLs) are a heterogeneous group of aggressive non-Hodgkin lymphomas. Angioimmunoblastic T-cell lymphoma (AITL) is a common subtype of PTCL, and patients with AITL typically have a poor prognosis with limited treatment options. Clinical studies have demonstrated...

Cite
Irlé C, Weintraub J. Long-Term Treatment with Romidepsin in Patients with Peripheral T-Cell Lymphoma. Case Rep Hematol. 2016;2016:8175957doi: 10.1155/2016/8175957.
Irlé, C., & Weintraub, J. (2016). Long-Term Treatment with Romidepsin in Patients with Peripheral T-Cell Lymphoma. Case reports in hematology, 20168175957. https://doi.org/10.1155/2016/8175957
Irlé, Claudius, and Weintraub, Jonathan. "Long-Term Treatment with Romidepsin in Patients with Peripheral T-Cell Lymphoma." Case reports in hematology vol. 2016 (2016): 8175957. doi: https://doi.org/10.1155/2016/8175957
Irlé C, Weintraub J. Long-Term Treatment with Romidepsin in Patients with Peripheral T-Cell Lymphoma. Case Rep Hematol. 2016;2016:8175957. doi: 10.1155/2016/8175957. Epub 2016 Aug 25. PMID: 27648317; PMCID: PMC5014944.
Copy Download .nbib Format: NLM
Structural Elucidation of the O-Antigen Polysaccharide from Escherichia coli O181.

ChemistryOpen

Fontana C, Weintraub A, Widmalm G.
PMID: 25861570
ChemistryOpen. 2015 Feb;4(1):47-55. doi: 10.1002/open.201402068. Epub 2014 Dec 01.

Shiga-toxin-producing Escherichia coli (STEC) is an important pathogen associated to food-borne infection in humans; strains of E. coli O181, isolated from human cases of diarrhea, have been classified as belonging to this pathotype. Herein, the structure of the O-antigen...

Cite
Fontana C, Weintraub A, Widmalm G. Structural Elucidation of the O-Antigen Polysaccharide from Escherichia coli O181. ChemistryOpen. 2014;4(1):47-55doi: 10.1002/open.201402068.
Fontana, C., Weintraub, A., & Widmalm, G. (2015). Structural Elucidation of the O-Antigen Polysaccharide from Escherichia coli O181. ChemistryOpen, 4(1), 47-55. https://doi.org/10.1002/open.201402068
Fontana, Carolina, et al. "Structural Elucidation of the O-Antigen Polysaccharide from Escherichia coli O181." ChemistryOpen vol. 4,1 (2015): 47-55. doi: https://doi.org/10.1002/open.201402068
Fontana C, Weintraub A, Widmalm G. Structural Elucidation of the O-Antigen Polysaccharide from Escherichia coli O181. ChemistryOpen. 2015 Feb;4(1):47-55. doi: 10.1002/open.201402068. Epub 2014 Dec 01. PMID: 25861570; PMCID: PMC4380953.
Copy Download .nbib Format: NLM
Neonatal withdrawal syndrome and behavioral effects produced by maternal drug use.

Addiction biology

Weintraub Z, Bental Y, Olivan A, Rotschild A.
PMID: 26734821
Addict Biol. 1998 Apr;3(2):159-70. doi: 10.1080/13556219872227.

Over the last two decades, drug and alcohol abuse by pregnant women has spread to epidemic proportions. Maternal drug abuse has neurobehavioral and somatic effects which may be long-lasting and devastating to the offspring. Opiates, such as heroin and...

Cite
Weintraub Z, Bental Y, Olivan A, et al. Neonatal withdrawal syndrome and behavioral effects produced by maternal drug use. Addict Biol. 1998;3(2):159-70doi: 10.1080/13556219872227.
Weintraub, Z., Bental, Y., Olivan, A., & Rotschild, A. (1998). Neonatal withdrawal syndrome and behavioral effects produced by maternal drug use. Addiction biology, 3(2), 159-70. https://doi.org/10.1080/13556219872227
Weintraub, Z, et al. "Neonatal withdrawal syndrome and behavioral effects produced by maternal drug use." Addiction biology vol. 3,2 (1998): 159-70. doi: https://doi.org/10.1080/13556219872227
Weintraub Z, Bental Y, Olivan A, Rotschild A. Neonatal withdrawal syndrome and behavioral effects produced by maternal drug use. Addict Biol. 1998 Apr;3(2):159-70. doi: 10.1080/13556219872227. PMID: 26734821.
Copy Download .nbib Format: NLM
Assessing the incremental benefit of an extended duration lifestyle intervention for the components of the metabolic syndrome.

Diabetes, metabolic syndrome and obesity : targets and therapy

Walden P, Jiang Q, Jackson EA, Oral EA, Weintraub MS, Rubenfire M.
PMID: 27330320
Diabetes Metab Syndr Obes. 2016 Jun 01;9:177-84. doi: 10.2147/DMSO.S94772. eCollection 2016.

BACKGROUND: Lifestyle interventions targeting the components of the metabolic syndrome (MetSyn) have been demonstrated to be a cost-effective and suitable treatment strategy for reducing one's risk of developing coronary artery disease and diabetes. The optimal duration has not yet...

Cite
Walden P, Jiang Q, Jackson EA, et al. Assessing the incremental benefit of an extended duration lifestyle intervention for the components of the metabolic syndrome. Diabetes Metab Syndr Obes. 2016;9:177-84doi: 10.2147/DMSO.S94772.
Walden, P., Jiang, Q., Jackson, E. A., Oral, E. A., Weintraub, M. S., & Rubenfire, M. (2016). Assessing the incremental benefit of an extended duration lifestyle intervention for the components of the metabolic syndrome. Diabetes, metabolic syndrome and obesity : targets and therapy, 9177-84. https://doi.org/10.2147/DMSO.S94772
Walden, Patrick, et al. "Assessing the incremental benefit of an extended duration lifestyle intervention for the components of the metabolic syndrome." Diabetes, metabolic syndrome and obesity : targets and therapy vol. 9 (2016): 177-84. doi: https://doi.org/10.2147/DMSO.S94772
Walden P, Jiang Q, Jackson EA, Oral EA, Weintraub MS, Rubenfire M. Assessing the incremental benefit of an extended duration lifestyle intervention for the components of the metabolic syndrome. Diabetes Metab Syndr Obes. 2016 Jun 01;9:177-84. doi: 10.2147/DMSO.S94772. eCollection 2016. PMID: 27330320; PMCID: PMC4898037.
Copy Download .nbib Format: NLM
Acute Coronary Syndrome In HIV Naïve Patient With Low CD4 Count And No Other Significant Risk Factors: Case Report And Literature Review.

Open journal of clinical & medical case reports

Fanari Z, Hammami S, Hammami MB, Weintraub WS, Qureshi WA.
PMID: 26065032
Open J Clin Med Case Rep. 2015;1(2).

Coronary artery disease (CAD) has become the leading cause of mortality in patients with Human Immunodeficiency Virus (HIV). The typical HIV-infected patient presenting with acute coronary syndrome (ACS) is a man in his mid to late 40s. The most...

Cite
Fanari Z, Hammami S, Hammami MB, et al. Acute Coronary Syndrome In HIV Naïve Patient With Low CD4 Count And No Other Significant Risk Factors: Case Report And Literature Review. Open J Clin Med Case Rep. 2015;1(2)
Fanari, Z., Hammami, S., Hammami, M. B., Weintraub, W. S., & Qureshi, W. A. (2015). Acute Coronary Syndrome In HIV Naïve Patient With Low CD4 Count And No Other Significant Risk Factors: Case Report And Literature Review. Open journal of clinical & medical case reports, 1(2), .
Fanari, Zaher, et al. "Acute Coronary Syndrome In HIV Naïve Patient With Low CD4 Count And No Other Significant Risk Factors: Case Report And Literature Review." Open journal of clinical & medical case reports vol. 1,2 (2015).
Fanari Z, Hammami S, Hammami MB, Weintraub WS, Qureshi WA. Acute Coronary Syndrome In HIV Naïve Patient With Low CD4 Count And No Other Significant Risk Factors: Case Report And Literature Review. Open J Clin Med Case Rep. 2015;1(2). PMID: 26065032; PMCID: PMC4459740.
Copy Download .nbib Format: NLM
[Difficulties and bias in attributing side effects to drugs].

La Nouvelle presse medicale

Weintraub M.
PMID: 7145685
Nouv Presse Med. 1982 Oct 14;11(40):3003-5.

A number of difficulties and bias are known to make difficult the establishment of the relation cause/effect of side effects. Five sources of difficulty can be identified: the patient, the disease, the drug, the doctor, the studies and data...

Cite
Weintraub M. Difficultés et biais dans l'attribution des effets indésirables des médicaments. [Difficulties and bias in attributing side effects to drugs]. Nouv Presse Med. 1982;11(40):3003-5
Weintraub, M. (1982). Difficultés et biais dans l'attribution des effets indésirables des médicaments. [Difficulties and bias in attributing side effects to drugs]. La Nouvelle presse medicale, 11(40), 3003-5.
Weintraub, M. "Difficultés et biais dans l'attribution des effets indésirables des médicaments." [Difficulties and bias in attributing side effects to drugs]. La Nouvelle presse medicale vol. 11,40 (1982): 3003-5.
Weintraub M. Difficultés et biais dans l'attribution des effets indésirables des médicaments. [Difficulties and bias in attributing side effects to drugs]. Nouv Presse Med. 1982 Oct 14;11(40):3003-5. French. PMID: 7145685.
Copy Download .nbib Format: NLM
A large-scale investigator-sponsored field study of the test performance of the ThinPrep papanicolaou test in a low-risk routine outpatient setting.

Primary care update for Ob/Gyns

Weintraub J, Wenger D.
PMID: 10838306
Prim Care Update Ob Gyns. 1998 Jul 01;5(4):164. doi: 10.1016/s1068-607x(98)00061-4.

The performance of the ThinPrep Papanicolaou test (TP)(CYTYC Corp., Boxborough, MA) was evaluated in a low- risk outpatient population in order to assess its efficacy in routine clinical use. A total of 18,246 cervical cytology samples were prepared using...

Cite
Weintraub J, Wenger D. A large-scale investigator-sponsored field study of the test performance of the ThinPrep papanicolaou test in a low-risk routine outpatient setting. Prim Care Update Ob Gyns. 1998;5(4):164doi: 10.1016/s1068-607x(98)00061-4.
Weintraub, J., & Wenger, D. (1998). A large-scale investigator-sponsored field study of the test performance of the ThinPrep papanicolaou test in a low-risk routine outpatient setting. Primary care update for Ob/Gyns, 5(4), 164. https://doi.org/10.1016/s1068-607x(98)00061-4
Weintraub, and Wenger. "A large-scale investigator-sponsored field study of the test performance of the ThinPrep papanicolaou test in a low-risk routine outpatient setting." Primary care update for Ob/Gyns vol. 5,4 (1998): 164. doi: https://doi.org/10.1016/s1068-607x(98)00061-4
Weintraub J, Wenger D. A large-scale investigator-sponsored field study of the test performance of the ThinPrep papanicolaou test in a low-risk routine outpatient setting. Prim Care Update Ob Gyns. 1998 Jul 01;5(4):164. doi: 10.1016/s1068-607x(98)00061-4. PMID: 10838306.
Copy Download .nbib Format: NLM
Antimicrobial susceptibility of anaerobicand aerobic bacteria isolated from patientswith mixed infections in Nicaragua.

Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia

Cáceres M, Carrera E, Palma A, Berrios G, Weintraub A, Nord CE.
PMID: 10878525
Rev Esp Quimioter. 1999;12(4):332-339.

The agar dilution method was used to test the activity of ampicillin, benzylpenicillin, cefoxitin, imipenem, clindamycin, metronidazole, chloramphenicol, gentamicin, methicillin and vancomycin against 241 anaerobic and 227 aerobic bacteria isolated from 136 patients with intraabdominal infections and 49 with...

Cite
Cáceres M, Carrera E, Palma A, et al. Antimicrobial susceptibility of anaerobicand aerobic bacteria isolated from patientswith mixed infections in Nicaragua. Rev Esp Quimioter. 1999;12(4):332-339
Cáceres, M., Carrera, E., Palma, A., Berrios, G., Weintraub, A., & Nord, C. E. (1999). Antimicrobial susceptibility of anaerobicand aerobic bacteria isolated from patientswith mixed infections in Nicaragua. Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 12(4), 332-339.
Cáceres, et al. "Antimicrobial susceptibility of anaerobicand aerobic bacteria isolated from patientswith mixed infections in Nicaragua." Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia vol. 12,4 (1999): 332-339.
Cáceres M, Carrera E, Palma A, Berrios G, Weintraub A, Nord CE. Antimicrobial susceptibility of anaerobicand aerobic bacteria isolated from patientswith mixed infections in Nicaragua. Rev Esp Quimioter. 1999;12(4):332-339. PMID: 10878525.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 391 entries